Contrast induced ne- phropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 2011;21:2527 41. 35. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous cor- onary intervention: development and initial validation. J Am Coll Cardiol 2004;44:1393 9. 36. Borden WB, Redberg RF, Mushlin AI, et al. Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention. JAMA 2011;305:1882 9. 37. Fonarow GC, Gawlinski A, Moughrabi S, et al. Improved treatment of coronary heart disease by implementation of a Cardiac Hospitali- zation Atherosclerosis Management Program (CHAMP). Am J Cardiol 2001;87:819 22. 38. National Cardiovascular Data Registry. Measures and Metrics. Available at: https://www.ncdr.com/WebNCDR/home/metrics-and- measures. Accessed May 10, 2013. 39. Goel K, Lennon RJ, Tilbury RT, et al. Impact of cardiac reha- bilitation on mortality and cardiovascular events after percutaneous coronary intervention in the community. Circulation 2011;123: 2344 52. 40. Taylor RS, Brown A, Ebrahim S, et al. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med 2004;116: 682 92. 41. Giannuzzi P, Temporelli PL, Marchioli R, et al. Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network. Arch Intern Med 2008;168:2194 204. 42. Witt BJ, Jacobsen SJ, Weston SA, et al. Cardiac rehabilitation after myocardial infarction in the community. J Am Coll Cardiol 2004;44: 988 96. 43. Thompson PD. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease. Arterioscler Thromb Vasc Biol 2003;23:1319 21. 44. Clark AM, Hartling L, Vandermeer B, et al. Meta-analysis: sec- ondary prevention programs for patients with coronary artery disease. Ann Intern Med 2005;143:659 72. 45. 